MediPharm Labs Corp MEDIF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.05
- Day Range
- $0.05–0.06
- 52-Week Range
- $0.04–0.08
- Bid/Ask
- $0.05 / $0.07
- Shares Outstanding
- 427.18M
- Market Cap
- $23.56M
- Volume/Avg
- 10,136 / 65,387
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.78
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
MediPharm Labs Corp and its subsidiaries produce cannabis, purified and pharmaceutical-like cannabis extracts, related derivative products, and cannabis-related medical information and services. Its operating subsidiaries hold cultivation, standard processing, and sale licences under the Cannabis Act (Canada), allowing the cultivation, sale, and distribution of cannabis oil, extracts, edibles, topicals, dried and fresh cannabis, and derivatives to authorized purchasers. Its subsidiary provides clinic services to Canadian patients requiring medical cannabis education and prescriptions. The company operates in one reportable segment, the production and sales of cannabis flower, and generates maximum revenue from Canada, with additional international sales.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 127
- Website
- https://www.medipharmlabs.com
Valuation
|
Metric
|
MEDIF
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.95 |
Price/Sales | 0.78 |
Price/Cash Flow | — |
Price/Earnings
MEDIF
Financial Strength
|
Metric
|
MEDIF
|
|---|---|
Quick Ratio | 1.62 |
Current Ratio | 2.69 |
Interest Coverage | −82.92 |
Quick Ratio
MEDIF
Profitability
|
Metric
|
MEDIF
|
|---|---|
Return on Assets (Normalized) | −8.40% |
Return on Equity (Normalized) | −12.21% |
Return on Invested Capital (Normalized) | −10.92% |
Return on Assets
MEDIF
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|f@mK<GQ | LOCK|C<<b | $69B | |||
| Teva Pharmaceutical Industries Ltd ADR
TEVA
| LOCK|@X>$VG> | LOCK|q$<q | $42B | |||
| Haleon PLC ADR
HLN
| LOCK|C%?Gp&M | LOCK|&@ | $42B | |||
| Zoetis Inc Class A
ZTS
| LOCK|qMrW!^L% | LOCK|cDY | $31B | |||
| Viatris Inc
VTRS
| LOCK|W?C@Xf | LOCK|&Zh | $19B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|!g? | LOCK|JPQ | $12B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|GR<y%X | LOCK|kH^ | $10B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|V>k%cq | LOCK|$&x | $6B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|%d$snv | LOCK|P#X# | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|llpsS@ | LOCK|l% | $2B |
United States